Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy.
Tatyana KushnerAngelyn FairchildF Reed JohnsonBruce E SandsUma MahadevanSreedhar SubramanianAshwin AnanthakrishnanChristina HaMeenakshi BewtraPublished in: The patient (2021)
Women with IBD demonstrated a strong preference for avoiding disease activity during pregnancy. Knowledge regarding pregnancy and IBD was a strong modifier of preferences for continuation of IBD medications during pregnancy. These findings point to an important opportunity for intervention to improve disease control through education to increase medication adherence and alleviate unnecessary fears about IBD medication use during pregnancy.
Keyphrases
- disease activity
- ulcerative colitis
- healthcare
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- randomized controlled trial
- ankylosing spondylitis
- pregnancy outcomes
- polycystic ovary syndrome
- juvenile idiopathic arthritis
- preterm birth
- emergency department
- quality improvement
- pregnant women
- adipose tissue
- insulin resistance
- electronic health record
- breast cancer risk